FDA Biosimilars Plan Draws From Experience With Generics
On May 11, 2018, President Donald Trump issued his blueprint to lower drug prices that describes the Administration's plan to reduce the price of prescription drugs by, among other actions, "[a]dvanc[ing]...To view the full article, register now.
Already a subscriber? Click here to view full article